At a glance
Corteva Inc is worth $7.95B, about 7 times its fiscal 2025 earnings. Revenue grew 2.9% to $17.40B in fiscal 2025, with 6.3% kept as profit; over 5 years it has grown 4.1% a year. It pays a 0.91% dividend yield, raised every year for at least 4 years, and returned $6.97B to shareholders in dividends and buybacks over FY2021–FY2025. The stock returned +30.5% over the past year with dividends reinvested and +14.4% a year over five years, against +11.5% and +11.7% for the S&P 500. At its worst it fell 34.0% in the 2020 crash (S&P 500: 33.7%) and 19.4% in the 2022 bear market (S&P 500: 24.5%), and was back at its earlier high 7 months and 2 months after the lows.
The business in plain English
Corteva supplies two things farmers need to grow crops: seed and crop protection products. Based in Indianapolis, it serves farmers in about 110 countries. Its Seed segment develops corn, soybean and other seed that pairs high-yielding genetics with biotech traits. These are built-in features that help plants withstand weather, pests, disease and the weed killers farmers spray. Brands include Pioneer and Brevant, and in 2025 substantially all of its branded soybeans offered the Enlist E3 trait. Crop Protection offers herbicides, insecticides, fungicides, nitrogen stabilizers and biological products.
In 2025, revenue was $17.4 billion. Seed brought in $9.9 billion, or 56.9%, and Crop Protection $7.5 billion, or 43.1%. The United States made up 47.5% of sales, Latin America 22.6%, Europe, the Middle East and Africa 17.9%, Asia Pacific 7.7% and Canada 4.3%. Seed reaches farmers through the Pioneer agency model, in which independent sales representatives deal directly with farmers. It also reaches them through regional brands, retailers and licensing deals with other companies.
Corteva became an independent public company on June 1, 2019, when DowDuPont spun it off. On October 1, 2025, it announced plans to split Seed and Crop Protection into two public companies through a spin-off, where shareholders receive shares of the new company. The split is intended to be tax-free for US federal income tax purposes.
Price history
The interactive chart needs JavaScript.
CTVA +30.5% over the year to Nov 2, 2026, total return with dividends reinvested.
How it makes money
By business segment
| Seed | $9.90B | 56.9% |
| Crop Protection | $7.50B | 43.1% |
By geography
| UNITED STATES | $8.27B | 47.5% |
| Latin America | $3.93B | 22.6% |
| EMEA | $3.11B | 17.9% |
| Asia Pacific | $1.34B | 7.7% |
| CANADA | $755.0M | 4.3% |
Latest results
- In Q2 FY2026 (ended Jun 30, 2026), revenue was $6.38B, down 1.2% from a year earlier, and net income was $1.16B (-11.6%).
- For fiscal 2025, revenue was $17.40B (+2.9% year over year; +4.1% a year from FY2020 to FY2025) with a 6.3% net margin.
Financial health check
| Revenue growth a year (FY2020–FY2025) | +4.1% watch |
|---|---|
| Free cash flow margin | 16.2% good |
| Return on equity (FY2025) | 4.5% weak |
| Return on assets (FY2025) | 2.6% weak |
| Net cash (cash minus debt) | $683.0M good |
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| FY2020 | $14.22B | $681.0M | $1.59B |
| FY2021 | $15.65B | $1.76B | $2.15B |
| FY2022 | $17.45B | $1.15B | $267.0M |
| FY2023 | $17.23B | $735.0M | $1.17B |
| FY2024 | $16.91B | $907.0M | $1.55B |
| FY2025 | $17.40B | $1.09B | $2.81B |
Valuation snapshot
| Market value | $7.95B |
|---|---|
| P/E ratio | 7.4 |
| Dividend yield | 0.91% |
Rank among 1514 US companies
Market value at each year end
Corteva’s market value went from $3.32B at the end of 2019 to $7.95B on Nov 2, 2026, about 2.4 times as much; since the end of 2025 it is up 17%.
Show as a table
| Year end | Market value | Change |
|---|---|---|
| Nov 2, 2026 | $7.95B | +17.0% |
| 2025 | $6.80B | +15.7% |
| 2024 | $5.87B | +15.9% |
| 2023 | $5.07B | -19.6% |
| 2022 | $6.30B | +21.9% |
| 2021 | $5.17B | +19.5% |
| 2020 | $4.33B | +30.4% |
| 2019 | $3.32B |
Price behavior
| YTD | 1 yr | 3 yr | 5 yr | 10 yr | |
|---|---|---|---|---|---|
| CTVA price data to Nov 2, 2026 | +19.3% | +30.5% | +18.3% | +14.4% | — |
Show as a table
| Year | Price data |
|---|---|
| 2026 (to date) | +19.3% |
| 2025 | +18.9% |
| 2024 | +20.3% |
| 2023 | -17.5% |
| 2022 | +25.6% |
| 2021 | +23.5% |
| 2020 | +33.5% |
| 2008 financial crisis stocks fell Oct 9, 2007 – Mar 9, 2009 | Before this security existed |
|---|---|
| 2020 COVID crash stocks fell Feb 19, 2020 – Mar 23, 2020 | Lost 30.1% over that stretch · deepest drop along the way 34%, back to its old high 6.8 months after the low |
| 2022 bear market stocks fell Jan 3, 2022 – Oct 12, 2022 | Gained 30.6% over that stretch · deepest drop along the way 19.4%, back to its old high 2.1 months after the low |
Insider activity
Form 4 filings from 2025-10-27 to 2026-10-27 (25 read): 0 open-market purchases and 0 sales ($0.00).
Who owns it
Large shareholders (13G filings)
| Vanguard Capital Management | 7.56% | Mar 31, 2026 |
| Capital World Investors | 6.6% | Jun 30, 2026 |
| FMR LLC | 5.2% | Mar 31, 2026 |
| STATE STREET CORPORATION | 5.2% | Sep 30, 2025 |
ETFs with the most weight in CTVA
| KROP Global X AgTech & Food Innovation ETF | 12.73% |
| FTAG First Trust Indxx Global Agriculture ETF | 9.56% |
| VEGI iShares MSCI Agriculture Producers ETF | 9.17% |
| MOO VanEck Agribusiness ETF | 7.36% |
| GUNR FlexShares Morningstar Global Upstream Natural Resources Index Fund | 5.04% |
| PBJ Invesco Food & Beverage ETF | 4.78% |
| XLB Materials Select Sector SPDR Fund | 4.67% |
| NRES Xtrackers RREEF Global Natural Resources ETF | 4.57% |
What could go wrong
- The planned split could stumble. Corteva plans to spin Seed and Crop Protection into two public companies. Its annual report warns the split may be delayed, may not happen at all, or may not deliver the hoped-for benefits.
- Product approvals can be denied or lost. Biotech seeds and crop chemicals need lengthy, costly approvals, and some countries require renewals under stricter standards. Interest-group lawsuits, including over Enlist One, and EPA and USDA staff cuts could block or slow sales.
- Growth depends on new products succeeding. Only a very small share of the chemicals, genes and seed lines Corteva tests ever reach market, and new launches take years. Weeds and insects that develop resistance can wear down existing products.
- Environmental, legal and leftover tax liabilities. Corteva faces possible environmental, litigation and other future costs. It also remains subject to certain possible tax bills of DowDuPont from the 2019 separation. Large claims could hurt results and finances.
- Public views on biotech crops matter. How the public views biotech seeds and other farm products can sway planting approvals, regulations and farmers' purchase decisions. Negative sentiment could reduce demand for Corteva's core products.
- Weather and climate swing each season. Corteva's sales follow the farming calendar. Unpredictable weather, unusual seasons and longer-term climate change can reduce what farmers plant and apply, hurting sales and earnings.
Recent events
- Other company announcement
- Executive or board change
- Change to shareholder rights; Other company announcement
- Major agreement signed; Acquisition or sale of assets completed
- Other company announcement
- Investor presentation or announcement
- Investor presentation or announcement; Other company announcement
- Other company announcement
- Major agreement signed; Change to shareholder rights
- Other company announcement
For income and retirement investors
Corteva pays a dividend and has raised it four years running. Dividends per share were $0.52 in 2020 and 2021, then rose each year to $0.70 in 2025, about 6.1% annual growth over five years. In 2025, dividends used 43.4% of earnings and only 16.9% of free cash flow (cash left after running and reinvesting in the business). Buybacks (share repurchases) have been the bigger tool: $4.8 billion from 2021 to 2025, versus $2.2 billion in dividends. The share count fell 8.5% between July 2021 and July 2026.
In the 2020 COVID crash the stock fell 34% from February 20 to March 16, 2020, and recovered in about 6.8 months. It held up far better in the 2022 bear market, gaining 30.6% between the market's January peak and October low. A single stock carries more risk than a diversified fund, because one company's setbacks can hit both its dividend and its share price.
Questions investors ask
How does Corteva make money?
Corteva makes money by supplying seed and crop protection products to farmers in about 110 countries. In 2025, revenue was $17.4 billion and net income was $1.09 billion. Seed, marketed under brands such as Pioneer and Brevant, brought in 56.9% of revenue. Crop Protection, which offers herbicides, insecticides, fungicides and biological products, brought in 43.1%. The United States was the largest market at 47.5% of sales, followed by Latin America at 22.6%.
Is Corteva splitting into two companies?
Yes, Corteva has announced that plan. On October 1, 2025, it said it intends to separate its Seed and Crop Protection businesses into two standalone public companies. The split would be a spin-off intended to be tax-free for US federal income tax purposes. In its annual report filed February 12, 2026, the company warned the split may not be completed on the planned timeline or at all. It also may not deliver the intended benefits. Later company filings give updates on its progress.
Does Corteva raise its dividend every year?
Not every year, but it has raised it four years in a row. Dividends per share were flat at $0.52 in 2020 and 2021, then rose to $0.58 in 2022, $0.62 in 2023, $0.66 in 2024 and $0.70 in 2025. That works out to about 6.1% growth a year. In 2025, dividends used 43.4% of earnings and 16.9% of free cash flow. Over 2021–2025, Corteva spent more than twice as much on buybacks as on dividends.
Is Corteva the same company as DuPont?
No. Corteva became its own publicly traded company on June 1, 2019, when DowDuPont spun it off to shareholders. Corteva owns EIDP, Inc., the company formerly known as E. I. du Pont de Nemours and Company. DuPont de Nemours, Inc. and Dow Inc. are separate companies. Some ties remain: Corteva is still subject to certain possible tax liabilities of DowDuPont tied to the separation.
How did Corteva stock hold up in market crashes?
Results have been mixed. In the 2020 COVID crash, Corteva fell 34% from February 20 to March 16, 2020. It recovered by October 8, 2020, about 6.8 months later. During the 2022 bear market it gained 30.6% between the market's January peak and October low, despite a 19.4% dip in May and June. It lost 17.5% in 2023. As of October 28, 2026, its largest drop since it began trading in 2019 was 34.8%.